Aeterna Zentaris
AEZS
$1.96
Share price
-1.01%
Change (1 day)
-28.73%
Change (1 year)
Categories
Aeterna Zentaris (AEZS) - Total debt
Total debt on the balance sheet as of September 2023 : $0.21 M
According to Aeterna Zentaris's latest financial reports the company's total debt is $0.21 M. A company’s total debt is the sum of all current and non-current debts.
Aeterna Zentaris - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.17 M | 11.18% |
| 2021-12-31 | $0.16 M | -12.5% |
| 2020-12-31 | $0.18 M | -79.62% |
| 2019-12-31 | $0.9 M | |
| 2018-12-31 | $N/A | |
| 2011-12-31 | $0.07 M | |
| 2008-12-31 | $0.22 M | -71.48% |
| 2007-12-31 | $0.77 M | -45.54% |
| 2006-12-31 | $1.42 M | -95.35% |
| 2005-12-31 | $30.58 M | -51.87% |
| 2004-12-31 | $63.55 M | 112.24% |
| 2003-12-31 | $29.94 M | -16.08% |
| 2002-12-31 | $35.67 M | 310.15% |
| 2001-12-31 | $8.69 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $26.34 B | 12,141,835.48% | 🇨🇭 Switzerland |
 Sanofi SNY | $20.36 B | 9,385,660.37% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $41.46 B | 19,107,734.10% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $28.84 M | 13,190.32% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $1.49 B | 690,798.62% | 🇺🇸 USA |